Hutch News

Hutch News

Stories tagged 'precision medicine'

Functional genomics provides a window into cancer's Achilles heels

Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA

May 10, 2018 | By Sabrina Richards / Fred Hutch News Service

New findings by Dr. Christopher Kemp and colleagues demonstrate how functional genomics can highlight potential drug targets in patients with head and neck cancer.

View story >


Early phase clinical trial shows promise for advanced head and neck cancer

Nine out of 10 patients treated with the experimental therapy saw their tumors shrink

April 13, 2018 | By Rachel Tompa / Fred Hutch News Service

When you look at Carla Stone, you might not guess that she was diagnosed with stage 4 head and neck cancer just two years ago. Stone participated in a clinical trial that shrank her advanced tumor down to nothing, allowing her to undergo a minimally invasive surgery.

View story >


A roadmap for precision colorectal cancer screening

New study combines environmental, lifestyle and genetic information to create a more nuanced risk-prediction model

March 15, 2018 | By Diane Mapes / Fred Hutch News Service

Public health researchers at Fred Hutch are working on a more nuanced risk-prediction model for colorectal cancer. What could it mean for you?

View story >


$7 million grants boost functional genomics team science

Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology

March 15, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Christopher Kemp and colleagues have received two grants from the National Cancer Institute totaling more than $7M to support their functional genomics research.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 7, 2017

Fred Hutch Pancreatic cancer researcher Dr. Sunil Hingorani has won a three-year, $1.8 million grant from the federal Cancer Moonshot program, the signature initiative of former Vice President Joseph Biden. Hingorani is one of six collaborators nationwide who received funding this fall for a new research consortium focused on the biological context of pancreatic tumors — such as nearby immune cells or blood vessels — which can have a major impact on a tumor’s vulnerability to treatment.

View story >


Q & A with Dr. Peggy Porter: Targeted breast cancer treatments require diverse research data

Breast cancer researcher discusses need to extend research and results to minority women

Oct. 26, 2017 | By Sabrina Richards and Diane Mapes / Fred Hutch News Service

Personalized breast cancer treatments must come to everyone -- and that requires study data from diverse populations, says breast cancer researcher Dr. Peggy Porter.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.